All biotech firms depend on their intellectual property rights. Their IP rights, often patents, will either be a result of the firm's own R&D or they may have been bought or licensed in from another party. In addition to establishing rights, biotech firms in particular often need to perform IP due diligence analyses to establish the exact scope and value of their IPR e.g. when they seek new investors or in connection with licensing agreements.
Patenting of biotech inventions offers special challenges, which require an updated knowledge on special patent case law in Europe.
Savic Patentanwälte will help you do all this. Our patent attorneys have vast experience in the field of biotech patents and in providing intellectual property consulting to the biotech industry throughout Europe.
